Cargando…
Glycosyltransferases in Cancer: Prognostic Biomarkers of Survival in Patient Cohorts and Impact on Malignancy in Experimental Models
SIMPLE SUMMARY: Cancer-associated glycosylation changes are widely used as biomarkers and strongly impact malignancy. However, the clinical significance of the deranged expression of glycosyltransferases observed in specimens is not always consistent with their role in experimental systems. We analy...
Autores principales: | Pucci, Michela, Duca, Martina, Malagolini, Nadia, Dall’Olio, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100214/ https://www.ncbi.nlm.nih.gov/pubmed/35565254 http://dx.doi.org/10.3390/cancers14092128 |
Ejemplares similares
-
Glycosyltransferase B4GALNT2 as a Predictor of Good Prognosis in Colon Cancer: Lessons from Databases
por: Pucci, Michela, et al.
Publicado: (2021) -
The Cancer-Associated Antigens Sialyl Lewis(a/x) and Sd(a): Two Opposite Faces of Terminal Glycosylation
por: Dall’Olio, Fabio, et al.
Publicado: (2021) -
Glycobiology of the Epithelial to Mesenchymal Transition
por: Pucci, Michela, et al.
Publicado: (2021) -
The Mutual Relationship between Glycosylation and Non-Coding RNAs in Cancer and Other Physio-Pathological Conditions
por: Duca, Martina, et al.
Publicado: (2022) -
The Sd(a) Synthase B4GALNT2 Reduces Malignancy and Stemness in Colon Cancer Cell Lines Independently of Sialyl Lewis X Inhibition
por: Pucci, Michela, et al.
Publicado: (2020)